Juno Therapeutics has been in the news lately; they "went public" on the NASDAQ exchange recently (you can look up the stock with the symbol JUNO). Juno was also featured in
Seattle Business magazine last month, in a fascinating article about the business climate for biotechnology here in Seattle. The article explores how Juno fits into that picture, and is well worth the time it takes to read; you can access it easily by clicking the link
HERE.
The day we have prayed for is drawing closer through this research - the day when we stop poisoning cancer patients with chemotherapy and radiation, and strengthen their bodies using their own immune system's T-cells. Katie would be thrilled - somehow, I believe that she IS thrilled.
